Analyst Ratings for Krystal Biotech (KRYS)
KRYS Rating Summary
KRYS Price Target Summary
- Highest: $403.00 (TD Cowen)
- Lowest: $327.00 (Goldman Sachs)
- Average: $378.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$378.33 (+9.5%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$378.33 (+9.5%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/14/2026 | RBC Capital | N/A | New Coverage | Outperform (N/A) |
400.00 (N/A) |
328.34 (345.60) |
5.26% | Details |
| 3/26/2026 | Wolfe Research | Kalpit Patel | New Coverage | Peerperform (N/A) |
N/A (N/A) |
254.95 (345.60) |
35.56% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
